M.von JonquieresG.KarlT.DruckerD
Mimicking one of the effects of bariatric surgery, namely the increased secretion of glucagon-like peptide (GLP)-1, by artificially increasing the levels of GLP-1 might prove successful as obesity treatment
This is the practical question most people reading this page are actually trying to answer
Using a compromised solution poses a significant safety risk to test subjects and will produce invalid data
Improvement and competition is expected over time, whether by creating more modifications to improve half-life , improving access to the brain, converting existing injectable drugs into oral forms, combining with other agonists or antagonists (Molecules that prevent receptors/molecules from functioning) such as DPP-4 inhibitors, which help extend the half-life of peptides such as GLP-1 and GIP
Nausea, vomiting, and stomach pain are common side effects, but they usually go away as your body gets used to the medication